| First Author | Omachi S | Year | 2017 |
| Journal | Biochem Biophys Res Commun | Volume | 489 |
| Issue | 4 | Pages | 528-533 |
| PubMed ID | 28583852 | Mgi Jnum | J:253852 |
| Mgi Id | MGI:6103515 | Doi | 10.1016/j.bbrc.2017.06.005 |
| Citation | Omachi S, et al. (2017) B-cell activating factor deficiency suppresses splenomegaly during Leishmania donovani infection. Biochem Biophys Res Commun 489(4):528-533 |
| abstractText | B-cell activating factor (BAFF) is a critical regulator for B-cell development and differentiation. We previously reported elevation of serum BAFF levels in patients with visceral leishmaniasis (VL). In this study, we examined if BAFF is involved in pathologies during infection of Leishmania donovani. BALB/cA mice infected with L. donovani showed significant elevation in serum BAFF and IgG levels as seen in VL patients. In contrast, elevation of serum IgG by L. donovani infection was significantly suppressed in BAFF-deficient mice. The spleen weight of the BAFF-deficient mice after infection was significantly lower than that of the infected wild-type mice, whereas comparable degree of hepatomegaly and anemia were observed in those mice. In the enlarged spleen of L. donovani-infected wild-type mice, increase of CD19(+) lymphocytes was more prominent than that of CD3(+) cells, suggesting the contribution of B cell increase to splenomegaly during VL. Besides, increase of CD19(+) lymphocytes was not found in BAFF-deficient mice after L. donovani infection. Taken together, these results suggest that BAFF is involved in strong B cell activation, which has a pathological role in splenomegaly but not in hepatomegaly or anemia, during VL. |
